Skip to main content
. 2020 Jun 5;17(7):2734–2748. doi: 10.1021/acs.molpharmaceut.0c00419

Figure 1.

Figure 1

Schematic representation of cytotoxic payloads and FGF2 conjugates: (A) chemical structure of cytotoxic agent–auristatin Y with dipeptide (l-Thr-d-Val) linker and maleimide (maleimide-tvAY); (B) PEGylated derivatives of auristatin Y; (C) conjugates utilized in this study vs previously published construct (in the frame).36